MannKind

MannKind Corporation, located in Valencia, California, is dedicated to the development and commercialization of innovative therapeutic products and delivery devices specifically for individuals living with endocrine and orphan lung diseases. Their mission is driven by a team of solutions-based scientists and medical professionals focused on improving the quality of life for patients through advanced technology.

One of MannKind's notable innovations is the Technosphere inhalation technology, which has been utilized in products such as Afrezza, an inhaled insulin, and Tyvaso DPI, a treatment for pulmonary arterial hypertension. The company continues to expand its pipeline of research and development, aiming to address unmet medical needs in the realm of respiratory and metabolic health.

Generated from the website